GSKGSK
13F holders, Q3 2025 (September 30)5holders
0new positions
0sold out
$43.17avg. 13F price*
At the end of Q3 2025, 5 institutions reported holding GSK PLC (GSK) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Paradigm Asset Management Co. LLC ($56K), PARK CIRCLE Co ($21K) and Asset Planning,Inc ($11K).
- Company
- GSK PLC
- Filed as
- GLAXOSMITHKLINE PLC (Q3 2025)
- CUSIP
- 37733W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 320 shares sold, net −320 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Paradigm Asset Management Co. LLC | 0.01% | No change | 1,300 | $56K |
| PARK CIRCLE Co | 0.02% | Reduce -40.0% | 480 | $21K |
| Asset Planning,Inc | 0.01% | No change | 264 | $11K |
| Byrne Asset Management LLC | 0.00% | No change | 56 | $2K |
| Huntington National Bank | 0.00% | No change | 1 | $40 |
"% of holder's portfolio" is GSK's weight in each manager's 13F, not the share of GSK PLC the manager owns.